Navigation Links
Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
Date:1/14/2009

NEW YORK, Jan. 14 /PRNewswire/ -- With all the woes of the U.S. economy, many people and businesses are looking to China for better opportunities. After all, China is expected to become the fifth-largest pharmaceutical market in the world by 2010. As the world watches, China is becoming a driving force in the pharmaceutical industry. People who want to be viable in this marketplace must learn to either thrive or die in this dynamic field.

But to survive and thrive overseas, you need the right tools. That's why interest is swelling in an exclusive Pharma China Seminar. The one-day seminar is being offered for three different dates and venues (New Jersey: February 26, 2009; Boston, MA: April 29, 2009; and San Francisco, CA: November 4, 2009).

In just one day, participants will be in the enviable position of learning everything they need to know (and have always wanted to know) about the Chinese Pharmaceutical Industry. This one-of-a-kind seminar is jampacked with the most recent, hard-to-find data, exclusive information, and real-world, on the ground experience you can't find anywhere else.

Momentum is building for this seminar, as participants say they're signing up to help solidify their roles as key players in the pharma industry's growth and expansion.

The following topics will be covered in-depth: regulatory structure, segmentation (hospital, ethical & OTC drugs, vaccines/bio, and others), environment and related issues; intellectual property/patent related issues; pricing and reimbursement/health insurance system; insights into various aspects of Chinese pharma including outsourcing (manufacturing, R&D, licensing/marketing/sales), API/intermediates sector, generic drugs, emerging Chinese global companies, IPOs/M&As/industry consolidation, and emerging pharma/biotech innovation; strategies and resources for market research and business intelligence; future growth drive
'/>"/>

SOURCE Pharma China Seminar
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cracking a tough nut for the semiconductor industry
2. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
3. Nikon Instruments Introduces Exclusive VAAS Detector Imaging Method for Confocal Microscopy
4. Exclusive Conference on Managing Your Online Brand: Shaping the Noise from the Blogosphere
5. Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts
6. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
7. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
8. VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research
9. Cryo-Cell Renews Upromise Industry-Exclusive Agreement
10. GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimers Disease Candidate Vaccines
11. Huifeng Bio-Pharmaceutical (HFGB) Signs Exclusive Management Operating Agreement with Xian Qinba Xintong Medical Ltd.; HFGB to Retain Up to 70% of Qinbas Total Profit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MN (PRWEB) May 28, 2015 ... it a point to ask his audiences if ... future trends including robotics, solar cells, fuel cells, ... 3D printers, advanced battery storage technology, driverless cars, ... and high-quality but inexpensive online education. , ...
(Date:5/28/2015)... Rochelle, Virginia (PRWEB) May 28, 2015 ... Partners LLC announced today that Roger L. Williams, ... Expert consultant. NDA Partners Premier Experts are top ... them to bring extraordinary value to the company’s ... critical solutions to help clients successfully develop their ...
(Date:5/28/2015)... 2015 Clinerion, an eClinical ... and the Alliance for Clinical Research Excellence ... organization operating in the public interest and ... enhance quality, safety, integrity and operational effectiveness ... are pleased to announce their partnership for ...
(Date:5/27/2015)... Mass. , May 27, 2015 ... biotechnology company focused on discovering and developing innovative ... ophthalmology, today announced that it has commenced a public ... to purchase shares of its common stock and ... common stock. The shares of common stock, warrants ...
Breaking Biology Technology:Futurist Jack Uldrich to Deliver 4 Keynote Addresses in June 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3
... fusions in lysates of the yeast Saccharomyces cerevisiae ... Cary Eclipse , Paul Gavin # ... J. Fyfe, Ph.D* , # Department ... Clayton campus Victoria 3800, Australia , * Technical ...
... Purpose , ... identified and quantified more effectively and efficiently using LC/MS/MS. These agricultural ... , Overview , ... organizations worldwide are placing great importance on the identification and quantitation ...
... Abstract , ... tools in the biological sciences. In drug discovery research, ... tissue culture supernatants of treated cells. However, scientists often ... require cumbersome manipulations. Applied Biosystems has developed a singlestep, ...
Cached Biology Technology: Monitoring fluorescence resonance energy transfer (FRET) between GFP, fusions in lysates of the yeast Saccharomyces cerevisiae using the , Varian, Cary Eclipse 2 Monitoring fluorescence resonance energy transfer (FRET) between GFP, fusions in lysates of the yeast Saccharomyces cerevisiae using the , Varian, Cary Eclipse 3 Monitoring fluorescence resonance energy transfer (FRET) between GFP, fusions in lysates of the yeast Saccharomyces cerevisiae using the , Varian, Cary Eclipse 4Identification of Insecticides and Herbicides by LC/MS/MS Using the API 2000 LC/MS/MS System 2Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 2Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 3Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 4Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 5
(Date:5/14/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has ... in Smart Mobile Devices " report to their ... a watershed year for fingerprint sensors in smartphones and ... gave fingerprint sensors a raison d,etre in the mobile ... a must-have feature in flagship smartphones. The ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/6/2015)... May 6, 2015 LifeBEAM, a developer of ... producer, announced today that they will expand their partnership ... first bio-sensing cycling helmet and the first joint project ... new colors in order to give cyclists more style ... addition, LifeBEAM and Lazer announced their plan to release ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... stick to surfaces depends partly on how stiff those ... of polymers that could be applied to medical devices ... inexpensive, easy-to-produce films could provide a valuable layer of ... reduce the spread of hospital-acquired infections, which take the ...
... CA - Now that high school biology students can ... transcribed into messenger RNA (mRNA), which is then translated ... sending studentsand many scientistsscrambling for updated textbooks. A ... Ecker, Ph.D., reported in the May 15, 2008 online ...
... profits be used to help turn companies green by ... of Six Sigma and Competitive Advantage (IJSSCA), researchers in ... Prabhakar Kaushik of NC College of Engineering in Haryana, ... forefront of company efforts. In a global economy with ...
Cached Biology News:MIT crafts bacteria-resistant films 2MIT crafts bacteria-resistant films 3Plant biologists discover unexpected proteins affecting small RNAs 2Plant biologists discover unexpected proteins affecting small RNAs 3Adding up business and energy 2
Request Info...
... is a nonspecific endonuclease that degrades double-and ... hydrolyzing phosphodiester linkages, producing mono and oligonucleotides ... Ambion's RNase-free DNase I is of the ... degrade DNA in the presence of RNA ...
hnRNP U (H-94)...
... GELase™ Agarose Gel-Digesting Preparation contains a unique ... simple, quantitative recovery of intact DNA and ... gels following electrophoresis in TAE, TBE, MOPS, ... digested directly in the TAE, TBE, MOPS, ...
Biology Products: